# Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)

> **NCT04779424** · — · COMPLETED · sponsor: **Universiteit Antwerpen** · enrollment: 3390 (actual)

## Conditions studied

- SARS-CoV-2
- COVID-19

## Interventions

- **OTHER:** POCT

## Key facts

- **NCT ID:** NCT04779424
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-15
- **Primary completion:** 2021-12-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 3390 (ACTUAL)
- **Last updated:** 2023-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04779424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04779424, "Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04779424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*